Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Association of multiplex-immunofluorescence (m-IF) and gene expression signature with prognosis and bevacizumab (bev) treatment outcomes in NRG oncology/NSABP C-08: Implications for combining immune checkpoint blockade (ICB) and bev | JOURNAL OF CLINICAL ONCOLOGY |